$HQY
HEALTHEQUITY, INC.

2020 Q2 Form 10-Q Financial Statement

#000142833620000019 Filed on June 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $190.0M $87.05M
YoY Change 118.27% 24.53%
Cost Of Revenue $81.94M $29.30M
YoY Change 179.66% 14.68%
Gross Profit $108.1M $57.75M
YoY Change 87.13% 30.2%
Gross Profit Margin 56.88% 66.34%
Selling, General & Admin $30.45M $17.68M
YoY Change 72.26% 23.05%
% of Gross Profit 28.18% 30.61%
Research & Development $31.08M $10.91M
YoY Change 184.99% 36.67%
% of Gross Profit 28.76% 18.88%
Depreciation & Amortization $27.51M $4.773M
YoY Change 476.3% 5.6%
% of Gross Profit 25.45% 8.26%
Operating Expenses $93.00M $30.08M
YoY Change 209.24% 26.28%
Operating Profit $15.07M $27.68M
YoY Change -45.55% 34.75%
Interest Expense $12.26M $63.00K
YoY Change 19365.08% -68.5%
% of Operating Profit 81.37% 0.23%
Other Income/Expense, Net -$13.03M $23.60M
YoY Change -155.2% -2360100.0%
Pretax Income $2.044M $51.28M
YoY Change -96.01% 149.66%
Income Tax $218.0K $9.456M
% Of Pretax Income 10.67% 18.44%
Net Earnings $1.826M $41.82M
YoY Change -95.63% 85.24%
Net Earnings / Revenue 0.96% 48.04%
Basic Earnings Per Share $0.03 $0.67
Diluted Earnings Per Share $0.03 $0.65
COMMON SHARES
Basic Shares Outstanding 70.98M shares 62.33M shares
Diluted Shares Outstanding 72.29M shares 63.90M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $171.1M $329.3M
YoY Change -48.04% 22.05%
Cash & Equivalents $171.1M $329.3M
Short-Term Investments
Other Short-Term Assets $42.90M $8.244M
YoY Change 420.39% -23.17%
Inventory
Prepaid Expenses
Receivables $69.79M $27.02M
Other Receivables $0.00 $0.00
Total Short-Term Assets $283.8M $364.6M
YoY Change -22.16% 20.02%
LONG-TERM ASSETS
Property, Plant & Equipment $35.82M $8.481M
YoY Change 322.37% -1.68%
Goodwill $1.333B $4.651M
YoY Change 28552.57% 0.0%
Intangibles $777.5M $81.44M
YoY Change 854.7% -0.87%
Long-Term Investments $209.0K
YoY Change 109.0%
Other Assets $35.17M $21.51M
YoY Change 63.49% 18.02%
Total Long-Term Assets $2.279B $232.1M
YoY Change 881.93% 103.09%
TOTAL ASSETS
Total Short-Term Assets $283.8M $364.6M
Total Long-Term Assets $2.279B $232.1M
Total Assets $2.562B $596.6M
YoY Change 329.49% 42.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.338M $1.964M
YoY Change 273.63% -36.89%
Accrued Expenses $39.99M $9.127M
YoY Change 338.1% 42.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $46.88M
YoY Change
Total Short-Term Liabilities $134.6M $23.38M
YoY Change 475.78% 36.28%
LONG-TERM LIABILITIES
Long-Term Debt $1.167B $0.00
YoY Change
Other Long-Term Liabilities $3.783M $387.0K
YoY Change 877.52% -84.52%
Total Long-Term Liabilities $1.387B $387.0K
YoY Change 358355.81% -90.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $134.6M $23.38M
Total Long-Term Liabilities $1.387B $387.0K
Total Liabilities $1.522B $67.34M
YoY Change 2159.92% 219.8%
SHAREHOLDERS EQUITY
Retained Earnings $213.3M $213.7M
YoY Change -0.16% 77.28%
Common Stock $7.000K $6.000K
YoY Change 16.67% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.041B $529.3M
YoY Change
Total Liabilities & Shareholders Equity $2.562B $596.6M
YoY Change 329.49% 42.73%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $1.826M $41.82M
YoY Change -95.63% 85.24%
Depreciation, Depletion And Amortization $27.51M $4.773M
YoY Change 476.3% 5.6%
Cash From Operating Activities $15.03M $25.34M
YoY Change -40.69% 11.59%
INVESTING ACTIVITIES
Capital Expenditures $7.511M $1.126M
YoY Change 567.05% 0.45%
Acquisitions $0.00
YoY Change
Other Investing Activities $0.00 -$53.80M
YoY Change -100.0% 26800.0%
Cash From Investing Activities -$25.29M -$61.73M
YoY Change -59.02% 1716.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $7.812M $0.00
YoY Change
Cash From Financing Activities -$10.37M $4.229M
YoY Change -345.09% -58.4%
NET CHANGE
Cash From Operating Activities $15.03M $25.34M
Cash From Investing Activities -$25.29M -$61.73M
Cash From Financing Activities -$10.37M $4.229M
Net Change In Cash -$20.63M -$32.17M
YoY Change -35.85% -209.13%
FREE CASH FLOW
Cash From Operating Activities $15.03M $25.34M
Capital Expenditures $7.511M $1.126M
Free Cash Flow $7.515M $24.21M
YoY Change -68.96% 12.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001428336
CY2020Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2020Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q2 dei Amendment Flag
AmendmentFlag
false
CY2020Q2 dei Document Type
DocumentType
10-Q
CY2020Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q2 dei Document Period End Date
DocumentPeriodEndDate
2020-04-30
CY2020Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q2 dei Entity File Number
EntityFileNumber
001-36568
CY2020Q2 dei Entity Registrant Name
EntityRegistrantName
HEALTHEQUITY, INC.
CY2020Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2383166
CY2020Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
15 West Scenic Pointe Drive
CY2020Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2020Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Draper,
CY2020Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2020Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84020
CY2020Q2 dei City Area Code
CityAreaCode
801
CY2020Q2 dei Local Phone Number
LocalPhoneNumber
727-1000
CY2020Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2020Q2 dei Trading Symbol
TradingSymbol
HQY
CY2020Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71399355 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
171093000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191726000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1681000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1216000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69789000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70863000 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
42901000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
34711000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
283783000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
297300000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35821000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33486000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
97554000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
83178000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
777483000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
783279000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
1332631000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
1332631000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
38000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35169000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35089000 USD
CY2020Q2 us-gaap Assets
Assets
2562479000 USD
CY2020Q1 us-gaap Assets
Assets
2564981000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7338000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3980000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
27197000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50121000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39985000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46372000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
46875000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
39063000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13210000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12401000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
134605000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
151937000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
1521829000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1167192000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1181615000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
81982000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
68017000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3783000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2625000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
134267000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
130492000 USD
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1387224000 USD
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1382749000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
1534686000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71398000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71398000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71051000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71051000 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
7000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
7000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
827303000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
818774000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
213340000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
211514000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1040650000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1030295000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2562479000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2564981000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
190011000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87052000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
81937000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29299000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
108074000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
57753000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11455000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8970000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31078000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10905000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18998000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8709000 USD
CY2020Q2 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
18702000 USD
CY2019Q2 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
1491000 USD
CY2020Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
12770000 USD
CY2019Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
0 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
93003000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
30075000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15071000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27678000 USD
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2020Q2 us-gaap Interest Expense
InterestExpense
12263000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
63000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-764000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23663000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13027000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23600000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2044000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
51278000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9456000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1826000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1826000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
41822000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41822000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
529299000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1826000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
41822000 USD
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70980000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62326000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72292000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63901000 shares
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1030295000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
477079000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1040650000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27507000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4773000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7396000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6028000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1201000 USD
CY2019Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
15000 USD
CY2020Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
CY2019Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
23511000 USD
CY2020Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1494000 USD
CY2019Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-12000 USD
CY2020Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3786000 USD
CY2019Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
7542000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-552000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1354000 USD
CY2020Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8360000 USD
CY2019Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1694000 USD
CY2020Q2 hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-3104000 USD
CY2019Q2 hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-635000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3632000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1577000 USD
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-22924000 USD
CY2019Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8480000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2270000 USD
CY2019Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1769000 USD
CY2020Q2 hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-3045000 USD
CY2019Q2 hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-627000 USD
CY2020Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
1127000 USD
CY2019Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-17000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15026000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25336000 USD
CY2020Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2019Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
53845000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7511000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1126000 USD
CY2020Q2 us-gaap Payments For Software
PaymentsForSoftware
11775000 USD
CY2019Q2 us-gaap Payments For Software
PaymentsForSoftware
5497000 USD
CY2020Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
6008000 USD
CY2019Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1262000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25294000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61730000 USD
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7812000 USD
CY2019Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2020Q2 hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
3776000 USD
CY2019Q2 hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
0 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1223000 USD
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4229000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10365000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4229000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20633000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32165000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191726000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
361475000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171093000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
329310000 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
10749000 USD
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
50000 USD
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
733000 USD
CY2019Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-51000 USD
CY2020Q2 hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
0 USD
CY2019Q2 hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
141000 USD
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
968000 USD
CY2019Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
21000 USD
CY2020Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to prior year amounts to conform to the current year presentation.
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1826000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
41822000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70980000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62326000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70980000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62326000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1312000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1575000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72292000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63901000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55304000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49243000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19483000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15757000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35821000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33486000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
3900000 USD
CY2019Q2 us-gaap Depreciation
Depreciation
900000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3700000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4100000 USD
CY2020Q2 hqy Contract With Customer Recognition Term
ContractWithCustomerRecognitionTerm
P12M
CY2020Q2 hqy Contract With Customer Recognition Term Interchange Arrangement
ContractWithCustomerRecognitionTermInterchangeArrangement
P10Y
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 USD
CY2020Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
600000 USD
CY2019Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1343000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
0 USD
CY2019Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
23511000 USD
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
94000 USD
CY2019Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1184000 USD
CY2020Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1270000 USD
CY2019Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-764000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23663000 USD
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
4308000 USD
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1074000 USD
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
450000 USD
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
0 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
3858000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
1074000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y5M19D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0435
CY2020Q2 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P11Y
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9177000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
14517000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12348000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10318000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
10279000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
60429000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
117068000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21876000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
95192000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13210000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
81982000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
95192000 USD
CY2020Q2 hqy Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
63100000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3297000 USD
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
977000 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
17480000 USD
CY2019Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
199000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
899333000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
879597000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
122442000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
98851000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
776891000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
780746000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
777483000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
783279000 USD
CY2020Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
10300000 USD
CY2019Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
3900000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23600000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000 USD
CY2020Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2019Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2018Q3 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2018Q2 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1234400000 USD
CY2020Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
20300000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1214100000 USD
CY2020Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
20300000 USD
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0215
CY2020Q2 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0259
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
31300000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
62500000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
70300000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
101600000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
968700000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1234400000 USD
CY2020Q2 hqy Debt Instrument Covenant Description Acquisition Threshold For Maximum Total Net Leverage Ratio
DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio
100000000 USD
CY2020Q2 hqy Debt Instrument Covenant Description Interest Coverage Ratio
DebtInstrumentCovenantDescriptionInterestCoverageRatio
3.00 Rate
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9600000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.107
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.184
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.168
CY2019Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.045
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9400000 USD
CY2020Q1 hqy Unrecognized Tax Benefit Net
UnrecognizedTaxBenefitNet
500000 USD
CY2020Q2 hqy Unrecognized Tax Benefit Net
UnrecognizedTaxBenefitNet
500000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
8800000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7396000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6028000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7396000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6028000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
23.68
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.97
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3797
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.3598
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.3653
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0139
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0221
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0243
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M4D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2040000 shares
CY2020Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
0.10
CY2020Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.35
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
74009000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
16000 shares
CY2020Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Granted
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted
66.06
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
66.06
CY2020Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
51000 shares
CY2020Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised
0.10
CY2020Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised
44.53
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
22.07
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2020Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited
25.45
CY2020Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited
44.53
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
32.61
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2001000 shares
CY2020Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
0.10
CY2020Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.85
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M19D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
54009000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2001000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
30.85
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y8M19D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
54009000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1632000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
25.71
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M14D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
50730000 USD

Files In Submission

Name View Source Status
0001428336-20-000019-index-headers.html Edgar Link pending
0001428336-20-000019-index.html Edgar Link pending
0001428336-20-000019.txt Edgar Link pending
0001428336-20-000019-xbrl.zip Edgar Link pending
amendmentno1tokesslereea.htm Edgar Link pending
amendmentno1tokesslereea001.jpg Edgar Link pending
amendmentno1tokesslereea002.jpg Edgar Link pending
amendmentno1tokesslereea003.jpg Edgar Link pending
exhibit311-ceo302xfy21.htm Edgar Link pending
exhibit312-cfo302xfy21.htm Edgar Link pending
exhibit321-ceo906xfy21.htm Edgar Link pending
exhibit322-cfo906xfy21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hqy-20200430.htm Edgar Link pending
hqy-20200430.xsd Edgar Link pending
hqy-20200430_cal.xml Edgar Link unprocessable
hqy-20200430_def.xml Edgar Link unprocessable
hqy-20200430_htm.xml Edgar Link completed
hqy-20200430_lab.xml Edgar Link unprocessable
hqy-20200430_pre.xml Edgar Link unprocessable
hqyadreiertransitionse.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending